NeuroMedPro, LLC

Clinical Neuroscience Software Developers

NeuroMedPro is driven by a deep-seated mission to combat the debilitating effects of uncontrolled epilepsy, a problem our team of clinicians regularly witness firsthand. Epilepsy affects 65 million people worldwide (including 3 million adults and 470K children in the US), and one-third of these patients have seizures due to lesions resistant to treatment with medication.

Focal Cortical Displasia – a leading cause of drug-resistant epilepsy – can be automatically identified by NeuroMedPro with 90% or better accuracy and precision, saving diagnostic radiologists hours of manual review and significantly improving the probability of detection. Designed to integrate seamlessly with existing Electronic Health Record (EHR) workflows, NeuroMedPro significantly reduces the hours spent on a manual MRI review by the neurology care team.

We are also starting work on a second product, also using AI, to better detect seizures in infants in NICUs. Such a solution will alert staff earlier, especially for more subtle seizures.

We have received a $100,000 Technology Development Program award from the Arkansas Economic Development Commission. The Little Rock-based company uses emerging technologies to develop innovative neuroscience software. NeuroMedPro is a spinout of the University of Arkansas for Medical Sciences and Arkansas Children’s Hospital. NeuroMedPro will focus its TDP award on lesion detection in patients with medication-resistant epilepsy.

Read more in ASBTDC Lab2Launch Article

NeuroMedPro Wins State TDP Funding to Develop Brain Imaging Software

Dale McManis, PhD-Chief Executive Officer

Dale has two decades of experience in technology platform development and strategic planning, focusing since 2015 on health tech startup entrepreneurship. Along with two other founders, she has launched NeuroMedPro, and serves as the company’s Chief Executive Officer.

Mark McManis, PhD-Chief Scientific Officer

Mark has over 20 years of experience in clinical functional neuroimaging, combining neuroimaging and neurophysiology with statistics and programming to develop AI clinical neurodiagnostic software. Along with two other founders, Mark has launched NeuroMedPro, and serves as the company’s Chief Scientific Officer.

Fred Perkins, MD-Chief Medical Officer

Fred has over 20 years of experience in neurology as a board-certified epileptologist, working extensively on neurosurgery teams and is active in AI neuroimaging research and application. Along with two other founders, he has launched NeuroMedPro, and serves as the company’s Chief Medical Officer.

Sam Claassens, MEng, MBA-Technical Lead

Sam has over 15 years of experience developing enterprise systems for machine learning, artificial intelligence, and cloud SaaS products. He has co-founded multiple successful engineering startups, developed AI-based monitoring systems, and built HIPAA-compliant data transfer systems. He serves as the company's Technical Lead.

Jeff Amerine, PMP-Advisory Board

Jeff leads Startup Junkie Consulting, co-leads Innovation Junkie and Cadron Capital Partners, and is an adjunct professor of entrepreneurship at the Sam M. Walton College of Business at University of Arkansas. He is nationally recognized for the creation of lasting venture ecosystems and has made more than 90+ venture investments.

Jeff Standridge, EdD-Advisory Board

Jeff serves as Managing Director for the Conductor, Co-founder of Cadron Capital Partners, and teaches Entrepreneurial Finance & Innovation Leadership in the College of Business at the University of Central Arkansas. He helps organizations and their leaders generate sustained results in the areas of innovation, strategy, profit growth, organizational effectiveness, and leadership.

Jeff Stinson, CPA, MBA-Advisory Board

Jeff founded and leads HealthTech Arkansas, a healthcare accelerator/early stage investment fund immersing healthcare companies into Arkansas hospital systems and physician practices. He also founded and is executive director of the Fund for Arkansas’ Future, an “angel” investor fund for early stage, Arkansas-based companies, with 36 tech startups funded to date.

Kevin Sexton, MD-Advisory Board

Kevin is a surgeon-scientist with board certifications in Surgery and Clinical Informatics and has used this expertise to create software and medical devices. He serves as Associate Chief Medical Informatics Officer for Innovation, Research, and Entrepreneurship at UAMS; Associate Director of the UAMS Institute for Digital Health & Innovation; and President of BioVentures, LLC-the UAMS technology transfer office.